Immune Optimization

ARA-290

Activates the innate repair receptor for immune-mediated tissue protection without immunosuppressive effects.

Dr. Jonathan Snipes, MDMedically reviewed by Dr. Jonathan Snipes, MD. Last reviewed May 6, 2026.
Learn the Science ↓
Immune RecoveryTissue ProtectionNon-SuppressiveDual-Listed

What It Is

ARA-290 is dual-listed for its immune recovery properties. It activates repair pathways that support immune-mediated healing.

How It Works

Activates the innate repair receptor, supporting the immune system's role in tissue repair and recovery without suppressing immune function.

Who It's For

Those wanting immune support alongside tissue repair. See Recovery & Repair for full details.

Who Should Avoid It

Generally well-tolerated. Discuss with provider for specific conditions.


Protocol & Pricing

OBP Pharmacy Price

$80/30mg

You pay pharmacy price. No markup.

Starting Dose

20 units (1.2mg)

Form

Injectable vial (5mL, 6mg/mL, 30mg total)


Dosing Protocol

20 units subcutaneous injection daily. 20 units = 0.2mL × 6mg/mL = 1.2mg per injection.

Beyond Use Date

90 Days from compounding (USP <797>)

Use within this window from the date your vial is compounded. BUD is set per USP <797> sterile compounding standards and printed on every label.


Stacking Guide

Stacks Well With

thymosin-alpha1bpc-157

Related Peptides


Common questions about ARA-290

What is the ARA-290 immune formulation?
The ARA-290 immune formulation is a higher-concentration or alternate-dosing version of ARA-290 compounded by Optimal Balance Pharmacy for protocols emphasizing immune modulation rather than primary neuropathic pain. The active ingredient is identical to standard ARA-290; the formulation differs in concentration or carrier to support different protocol patterns.
How is the immune formulation different from standard ARA-290?
Same active peptide, different concentration and protocol target. The immune formulation is typically used for chronic inflammatory presentations (sarcoidosis-style inflammatory tone, autoimmune-spectrum protocols) rather than purely neuropathic indications. Your provider chooses between formulations based on the clinical picture.
How is the immune formulation dosed?
Protocols vary by indication. Common subcutaneous schedules deliver 1 to 4 mg per dose, 3 to 7 days per week, for 4 to 12 week courses. Optimal Balance Pharmacy compounds the formulation against PeptideRx prescriptions; your provider sets the protocol on your shipment sheet.
When should I take the ARA-290 immune protocol?
Most patients dose in the morning, but timing is not strict. Consistency over 4 to 8 weeks is more important than time of day. Track inflammatory markers (CRP, ESR) and symptom severity before, during, and after the course so you and your provider can decide whether continuation is warranted.
How is the immune formulation supplied?
Compounded by Optimal Balance Pharmacy under a 503A patient-specific prescription. Ships pre-reconstituted and ready to inject in cold-chain packaging. Every batch is tested by Eagle Analytical Services; the Certificate of Analysis is published on this product page.